Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{161794,
        author = {Swapnil Santosh Mali and Pratiksha Malhari Jadhav and Anisha Suresh Kadam and Rutuja Gajanan Wakale and Karuna Krishnat Mane and Mahesh Bandu Sawant and Rohit R. Todkar},
        title = {Overview On Blepharospasm},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {10},
        number = {6},
        pages = {189-193},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=161794},
        abstract = {The focal dystonia known as blepharospasm is typified by episodic, spasmodic, and involuntary closure of the eyelids. It's a degenerative illness that can become incapacitating and lower one's quality of life. Blepharospasm has a complex aetiology that can include both voluntary and involuntary control over the closing of one's eyelids, as well as damage to the corneal blink reflex. In clinical practice, the two most common types of involuntary eyelid closure observed are hemifacial spasm and benign essential blepharospasm. Because botulinum neurotoxin is so effective and has little side effects, it is currently the first line of treatment for blepharospasm.
Benign essential blepharospasm (BEB) is a type of craniofacial dyskinesia that is typified by involuntary contractions of the corrugator, procerus, and orbicularis muscles that occur repeatedly.},
        keywords = {Blepharitis, Blepharospasm, dystonia, dyskinesia, myectomy, myokymia.},
        month = {},
        }